Search

Search Constraints

You searched for: Author/Creator Hsu, Shih-Jer

Search Results

1. An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions. (8th April 2019)

2. IDDF2022-ABS-0181 Combination of post-daa liver fibrosis and neutrophil-to-lymphocyte ratio predicts the development of liver-associated complications in chronic hepatitis C patients who achieve sustained virologic response. (2nd September 2022)